This led to the decision to include a positive ANA on HEp-2 cell IFA “or an analogous positive test on other diagnostic platforms” at least once as an entrance requirement for the 2019 EULAR/ACR SLE Classification Criteria [2, 4, 5]. Here, BTG3 is linked to systemic lupus erythematosus.